Article in Arteriosclerosis, thrombosis, and vascular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Wei Zhang *Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Cardiovascular Research Center (W.Z., S.F., Y.Q.), Yale School of Medicine, New Haven, CT.ORCID 0000-0001-7693-9581
Lingfeng Qin *Department of Surgery (L.Q., G.T.), Yale University, New Haven, CT.ORCID 0000-0002-5381-6826
Saba Fooladi *Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Cardiovascular Research Center (W.Z., S.F., Y.Q.), Yale School of Medicine, New Haven, CT.ORCID 0000-0003-0835-1051
Séverine MénoretCenter for Research in Transplantation and Translational Immunology UMR1064, INSERM and SFR Santé, INSERM UMS 016, CNRS UMS 3556, Nantes Université, France (S.M., I.A.).ORCID 0000-0002-3234-1382
Alexandra JohnsDivision of General Internal Medicine, Division of Pediatric Cardiology, and Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN (A.J., T.J.N.).ORCID 0000-0002-4643-896X
Ignacio AnegonCenter for Research in Transplantation and Translational Immunology UMR1064, INSERM and SFR Santé, INSERM UMS 016, CNRS UMS 3556, Nantes Université, France (S.M., I.A.).ORCID 0000-0001-8700-5645
Timothy J NelsonDivision of General Internal Medicine, Division of Pediatric Cardiology, and Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN (A.J., T.J.N.).
George TellidesDepartment of Surgery (L.Q., G.T.), Yale University, New Haven, CT.ORCID 0000-0001-7042-8190
Yibing QyangSection of Cardiovascular Medicine, Department of Internal Medicine, Yale Cardiovascular Research Center (W.Z., S.F., Y.Q.), Yale School of Medicine, New Haven, CT.ORCID 0000-0002-0332-2449
Funding
Readily Available Stem Cell-Based Vascular Grafts for Emergent Surgical CareR01HL150352 · NHLBI · YALE UNIVERSITY · PI QYANG, YIBING · 2020 to 2023
$2.8M
Readily Available Biological Conduits to Treat Single Ventricle DefectsR01HL171984 · NHLBI · YALE UNIVERSITY · PI Yibing Qyang · 2024 to 2026
$1.7M
Development of HLA engineered universal vascular grafts from human iPSCsR01HL155411 · NHLBI · YALE UNIVERSITY · PI QYANG, YIBING · 2021 to 2024
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Shear Preconditioning Restores Endothelial Function of HLHS Patient-Derived iPSC-ECs for Successful Conduit Implantation. · full record | OpenQuestion